No Data
No Data
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
Bernstein Maintains Abbott Laboratories(ABT.US) With Buy Rating, Raises Target Price to $138
RBC Capital Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
103677010 : noted
103425615 : good
山芭佬 :
105489590 : k